| Oct 29 |
These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts
|
| Oct 15 |
Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
|
| Sep 24 |
VTYX Stock Rises on Strategic Equity Investment Deal With SNY
|
| Sep 23 |
Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal
|
| Sep 23 |
Ventyx stock climbs 8% on $27M Sanofi investment
|
| Sep 23 |
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
|
| Sep 6 |
Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease
|
| Aug 30 |
Ventyx Biosciences CFO departs
|
| Aug 30 |
Ventyx Biosciences Announces Departure of Chief Financial Officer
|
| Aug 30 |
Novo builds heart failure case for semaglutide; Ventyx CFO departs
|
